112 related articles for article (PubMed ID: 24953525)
21. ABCB4 disease mimicking morbus Wilson: A potential diagnostic pitfall.
Sticova E; Neroldova M; Kotalova R; Subhanova I; Jirsa M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):121-125. PubMed ID: 31728073
[TBL] [Abstract][Full Text] [Related]
22. Liver diseases related to MDR3 (ABCB4) gene deficiency.
Gonzales E; Davit-Spraul A; Baussan C; Buffet C; Maurice M; Jacquemin E
Front Biosci (Landmark Ed); 2009 Jan; 14(11):4242-56. PubMed ID: 19273348
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of ABCB4 impacts its function: insights from disease-causing mutations.
Gautherot J; Delautier D; Maubert MA; Aït-Slimane T; Bolbach G; Delaunay JL; Durand-Schneider AM; Firrincieli D; Barbu V; Chignard N; Housset C; Maurice M; Falguières T
Hepatology; 2014 Aug; 60(2):610-21. PubMed ID: 24723470
[TBL] [Abstract][Full Text] [Related]
24. MRCK-Alpha and Its Effector Myosin II Regulatory Light Chain Bind ABCB4 and Regulate Its Membrane Expression.
Bruneau A; Delaunay JL; Durand-Schneider AM; Vauthier V; Ben Saad A; Aoudjehane L; El Mourabit H; Morichon R; Falguières T; Gautheron J; Housset C; Aït-Slimane T
Cells; 2022 Feb; 11(4):. PubMed ID: 35203270
[TBL] [Abstract][Full Text] [Related]
25. ABCB4/MDR3 in health and disease - at the crossroads of biochemistry and medicine.
Prescher M; Kroll T; Schmitt L
Biol Chem; 2019 Sep; 400(10):1245-1259. PubMed ID: 30730833
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile salts.
Morita SY; Terada T
Biomed Res Int; 2014; 2014():954781. PubMed ID: 25133187
[TBL] [Abstract][Full Text] [Related]
27. Liver pathology in severe multidrug resistant 3 protein deficiency: a series of 10 pediatric cases.
Vij M; Safwan M; Shanmugam NP; Rela M
Ann Diagn Pathol; 2015 Oct; 19(5):277-82. PubMed ID: 26117383
[TBL] [Abstract][Full Text] [Related]
28. A PDZ-Like Motif in the Biliary Transporter ABCB4 Interacts with the Scaffold Protein EBP50 and Regulates ABCB4 Cell Surface Expression.
Venot Q; Delaunay JL; Fouassier L; Delautier D; Falguières T; Housset C; Maurice M; Aït-Slimane T
PLoS One; 2016; 11(1):e0146962. PubMed ID: 26789121
[TBL] [Abstract][Full Text] [Related]
29. Hepatocarcinogenesis in multidrug-resistant P-glycoprotein 3 deficiency.
Vij M; Shanmugam NP; Reddy MS; Govil S; Rela M
Pediatr Transplant; 2017 May; 21(3):. PubMed ID: 28127842
[TBL] [Abstract][Full Text] [Related]
30. Role of multidrug resistance 3 deficiency in pediatric and adult liver disease: one gene for three diseases.
Jacquemin E
Semin Liver Dis; 2001 Nov; 21(4):551-62. PubMed ID: 11745043
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow-derived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice.
Pennings M; Hildebrand RB; Ye D; Kunne C; Van Berkel TJ; Groen AK; Van Eck M
Cardiovasc Res; 2007 Oct; 76(1):175-83. PubMed ID: 17560559
[TBL] [Abstract][Full Text] [Related]
32. Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4
Wei G; Cao J; Huang P; An P; Badlani D; Vaid KA; Zhao S; Wang DQ; Zhuo J; Yin L; Frassetto A; Markel A; Presnyak V; Gandham S; Hua S; Lukacs C; Finn PF; Giangrande PH; Martini PGV; Popov YV
J Hepatol; 2021 Jun; 74(6):1416-1428. PubMed ID: 33340584
[TBL] [Abstract][Full Text] [Related]
33. The histidine-loop is essential for transport activity of human MDR3. A novel mutation of MDR3 in a patient with progressive familial intrahepatic cholestasis type 3.
Dzagania T; Engelmann G; Häussinger D; Schmitt L; Flechtenmacher C; Rtskhiladze I; Kubitz R
Gene; 2012 Sep; 506(1):141-5. PubMed ID: 22766396
[TBL] [Abstract][Full Text] [Related]
34. Effect of CFTR correctors on the traffic and the function of intracellularly retained ABCB4 variants.
Ben Saad A; Vauthier V; Tóth Á; Janaszkiewicz A; Durand-Schneider AM; Bruneau A; Delaunay JL; Lapalus M; Mareux E; Garcin I; Gonzales E; Housset C; Aït-Slimane T; Jacquemin E; Di Meo F; Falguières T
Liver Int; 2021 Jun; 41(6):1344-1357. PubMed ID: 33650203
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of ABCB4/MDR3 ATPase activity requires an intact phosphatidylcholine lipid.
Prescher M; Smits SHJ; Schmitt L
J Lipid Res; 2020 Dec; 61(12):1605-1616. PubMed ID: 32917728
[TBL] [Abstract][Full Text] [Related]
36. Effects of cellular, chemical, and pharmacological chaperones on the rescue of a trafficking-defective mutant of the ATP-binding cassette transporter proteins ABCB1/ABCB4.
Gautherot J; Durand-Schneider AM; Delautier D; Delaunay JL; Rada A; Gabillet J; Housset C; Maurice M; Aït-Slimane T
J Biol Chem; 2012 Feb; 287(7):5070-8. PubMed ID: 22184139
[TBL] [Abstract][Full Text] [Related]
37. Clinical and genetic study of ABCB4 gene-related cholestatic liver disease in China: children and adults.
Cao L; Ling X; Yan J; Feng D; Dong Y; Xu Z; Wang F; Zhu S; Gao Y; Cao Z; Zhang M
Orphanet J Rare Dis; 2024 Apr; 19(1):157. PubMed ID: 38610052
[TBL] [Abstract][Full Text] [Related]
38. Hepatobiliary transport in health and disease.
Chan J; Vandeberg JL
Clin Lipidol; 2012 Apr; 7(2):189-202. PubMed ID: 22859919
[TBL] [Abstract][Full Text] [Related]
39. RAB10 Interacts with ABCB4 and Regulates Its Intracellular Traffic.
Ben Saad A; Vauthier V; Lapalus M; Mareux E; Bennana E; Durand-Schneider AM; Bruneau A; Delaunay JL; Gonzales E; Housset C; Aït-Slimane T; Guillonneau F; Jacquemin E; Falguières T
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209301
[TBL] [Abstract][Full Text] [Related]
40. Case series of progressive familial intrahepatic cholestasis type 3: Characterization of variants in
Cheng J; Gong L; Mi X; Wu X; Zheng J; Yang W
Front Med (Lausanne); 2022; 9():962408. PubMed ID: 36569137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
